EcoDrugPlus

Ribosomal Protein L29

Ensembl ID : ENSLOCG00000013798
Gene Symbol: RPL29
3 Cross references
503 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSLOCG00000011210
Gene Symbol: RPL3
3 Cross references
335 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSLOCG00000009836
Gene Symbol: RPL30
3 Cross references
428 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSLOCG00000011235
Gene Symbol: RPL34
3 Cross references
362 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSLOCG00000008453
Gene Symbol: RPL35A
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSLOCG00000003106
Gene Symbol: RPL36
3 Cross references
395 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSLOCG00000011220
Gene Symbol: RPL37
3 Cross references
432 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSLOCG00000012842
Gene Symbol: RPL38
1 Cross references
205 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSLOCG00000015236
Gene Symbol: RPL39
1 Cross references
146 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSLOCG00000013867
Gene Symbol: RPL4
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L5b

Ensembl ID : ENSLOCG00000004677
Gene Symbol: RPL5B
1 Cross references
536 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSLOCG00000007680
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).